BIOMAT Database Logo BIOMAT Database Logo

Alteration of lipid profiles in plasma of transgenic mice expressing human lipoprotein lipase. 1994

M S Liu, and F R Jirik, and R C LeBoeuf, and H Henderson, and L W Castellani, and A J Lusis, and Y Ma, and I J Forsythe, and H Zhang, and E Kirk
Department of Medical Genetics, University of British Columbia, Vancouver, Canada.

Lipoprotein lipase (LPL) is a key enzyme required for the hydrolysis of triglyceride-rich particles. To assess the effects of increased plasma LPL on lipoprotein levels, transgenic mice expressing human LPL (hLPL) were produced. Abundant hLPL transcripts were detected in RNA from different tissues of transgenic mice which resulted in an increase in post-heparin plasma LPL activity of approximately 154%. On rodent chow (p = 0.01) and after a 16-h fast (p = 0.001), plasma triglycerides in transgenic mice were decreased by approximately 50% as compared to littermate controls. Gel filtration chromatography showed a 2-3-fold decrease in very low density lipoprotein triglycerides and cholesterol enrichment of low density lipoprotein. Transgenic mice maintained on a high carbohydrate diet exhibited a 78% (p = 0.03) lowering of low density lipoprotein and very low density lipoprotein cholesterol levels, in addition to a 68% (p = 0.01) lowering of total to high density lipoprotein cholesterol (TC/HDL-C) ratios compared to controls. The distribution of apoA-I and A-II were similar in the transgenics and their non-transgenic littermates, while the apoE distribution was mildly altered in the plasma from the transgenic mice. These data demonstrate that moderate increases in total LPL activity are associated with significant changes in lipoprotein levels and altered composition of lipoprotein particles.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008071 Lipoprotein Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34. Heparin-Clearing Factor,Lipemia-Clearing Factor,Diacylglycerol Lipase,Diglyceride Lipase,Post-Heparin Lipase,Postheparin Lipase,Postheparin Lipoprotein Lipase,Factor, Heparin-Clearing,Factor, Lipemia-Clearing,Heparin Clearing Factor,Lipase, Diacylglycerol,Lipase, Diglyceride,Lipase, Lipoprotein,Lipase, Post-Heparin,Lipase, Postheparin,Lipase, Postheparin Lipoprotein,Lipemia Clearing Factor,Lipoprotein Lipase, Postheparin,Post Heparin Lipase
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities

Related Publications

M S Liu, and F R Jirik, and R C LeBoeuf, and H Henderson, and L W Castellani, and A J Lusis, and Y Ma, and I J Forsythe, and H Zhang, and E Kirk
Transgenic rabbits expressing human lipoprotein lipase.
July 2000, Cytotechnology,
M S Liu, and F R Jirik, and R C LeBoeuf, and H Henderson, and L W Castellani, and A J Lusis, and Y Ma, and I J Forsythe, and H Zhang, and E Kirk
Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).
December 1993, The Journal of clinical investigation,
M S Liu, and F R Jirik, and R C LeBoeuf, and H Henderson, and L W Castellani, and A J Lusis, and Y Ma, and I J Forsythe, and H Zhang, and E Kirk
Regulation of plasma lipid homeostasis by hepatic lipoprotein lipase in adult mice.
July 2016, Journal of lipid research,
M S Liu, and F R Jirik, and R C LeBoeuf, and H Henderson, and L W Castellani, and A J Lusis, and Y Ma, and I J Forsythe, and H Zhang, and E Kirk
Caveolin-1 deficiency alters plasma lipid and lipoprotein profiles in mice.
March 2008, Biochemical and biophysical research communications,
M S Liu, and F R Jirik, and R C LeBoeuf, and H Henderson, and L W Castellani, and A J Lusis, and Y Ma, and I J Forsythe, and H Zhang, and E Kirk
Postnatal development of plasma-lipid-clearing enzymes (lipoprotein lipase, hepatic lipase and lecithin:cholesterol acyl transferase) and lipid profiles in suckling rats.
January 1992, Biology of the neonate,
M S Liu, and F R Jirik, and R C LeBoeuf, and H Henderson, and L W Castellani, and A J Lusis, and Y Ma, and I J Forsythe, and H Zhang, and E Kirk
Reduction of plasma triglycerides in apolipoprotein C-II transgenic mice overexpressing lipoprotein lipase in muscle.
January 2007, Journal of lipid research,
M S Liu, and F R Jirik, and R C LeBoeuf, and H Henderson, and L W Castellani, and A J Lusis, and Y Ma, and I J Forsythe, and H Zhang, and E Kirk
Plasma lipid levels and heart lipoprotein lipase activity in mice under social stress.
January 1984, Cor et vasa,
M S Liu, and F R Jirik, and R C LeBoeuf, and H Henderson, and L W Castellani, and A J Lusis, and Y Ma, and I J Forsythe, and H Zhang, and E Kirk
Transgenic mice expressing human lipoprotein lipase driven by the mouse metallothionein promoter. A phenotype associated with increased perinatal mortality and reduced plasma very low density lipoprotein of normal size.
July 1994, The Journal of biological chemistry,
M S Liu, and F R Jirik, and R C LeBoeuf, and H Henderson, and L W Castellani, and A J Lusis, and Y Ma, and I J Forsythe, and H Zhang, and E Kirk
Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
February 2005, Cardiovascular research,
M S Liu, and F R Jirik, and R C LeBoeuf, and H Henderson, and L W Castellani, and A J Lusis, and Y Ma, and I J Forsythe, and H Zhang, and E Kirk
Purification of human plasma lipoprotein lipase.
December 1980, Biochimica et biophysica acta,
Copied contents to your clipboard!